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CASE REPORT
In this article, the authors aim to highlight some of the complex issues surrounding wound healing. They will attempt to highlight how current dressing options can 
contribute to a considered approach 
to managing wounds, with particular 
reference to the ‘at-risk’ patient. In order 
to achieve this, the authors have included 
a case study, which demonstrates the 
practical application of dressings.  
FinAnCiAl buRdEn OF 
wOund CARE
Wound care has been described as 
being a high volume, high risk, high 
cost and unreliable healthcare activity. 
Delayed healing and infections related 
to inappropriate treatment can result in 
preventable pain and reduced quality of life 
(O’Brien et al, 2011).  
Tissue viability is a major area of 
expenditure for the acute and primary care 
sectors with the Department of Health 
(DoH) estimating costs at more than £80m 
in 1997. Additionally, wound dressings 
account for about £120m of prescribing 
costs in primary care in England each year 
(Shorney and Ousey, 2011).  
Chronic wounds, therefore, represent 
a significant burden to patients and the 
NHS. It is estimated that in the UK around 
200,000 patients have a chronic wound. A 
conservative estimate for the cost to the 
NHS of caring for patients with a chronic 
wound is £2.3bn–£3.1bn per year (Posnett 
and Franks, 2008). 
It has been suggested that with proper 
diagnosis and appropriate treatment, 
much of the burden could be avoided. 
Some of the symptoms, however, have a 
major impact on the lifestyle of a person 
suffering with chronic wounds. These 
may include ulceration involving pain, 
exudate and odour. These symptoms are 
frequently associated with poor sleep, loss 
of mobility and social isolation (Posnett 
and Franks, 2008). 
The DoH (2010a) has proposed a national 
programme of work streams that focus on 
long-term conditions, with the intention 
to improve quality and productivity across 
care pathways. It is fair to say, however, that 
the NHS faces many challenges at present, 
none more so than the pressure to achieve 
improved quality and productivity under 
severe economic pressure (Ousey and 
Bielby, 2011). 
With this is mind, the role of wound care, 
including wound care products, is crucial, in 
order to achieve optimum health outcomes 
for those experiencing ulceration.
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Table 1
Main wound care themes (Ousey et al, 2011)
The healthy process Holistic and wound  
assessment
Recognising risk factors
Identifying underlying 
aetiology
Correcting aetiology Wound infection
Prevention Recognising evidence-based 
care
Implementing valid and  
reliable evidence based-care
Wound bed preparation Product selection Patient education/health 
promotion
Follow-up Resource management and 
allocation
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wOundS
There are various definitions of what 
constitutes a chronic wound, with no 
universal agreement having been reached. 
Siddiqui and Bernstein (2010) state that 
most authors consider a wound to be 
chronic if it has not healed in four to six 
weeks, which may be further defined 
as a wound that has not shown a 20% 
to 40% reduction in its area after two 
to four weeks of optimal therapy. They 
suggest that standard surgical textbooks 
define chronic wounds as those that 
have not healed in three months and that 
regardless of the duration, wounds that 
fail to proceed through an orderly process, 
which produces an adequate anatomic and 
functional result, are considered chronic.
wOund CARE And ThE  
‘AT-RiSk’ PATiEnT
It is known that patients with chronic 
wounds are often older and have a higher 
incidence of comorbidities, such as heart 
disease, diabetes mellitus, peripheral 
arterial disease and neuropathy, among 
others (Siddiqui and Bernstein, 2010; 
Escandon et al, 2011). Therefore, these pre-
existing conditions would classify a patient 
as ‘at risk’ of developing a foot ulcer. 
These patients require expert care 
from appropriate members of the 
multidisciplinary team. The underpinning 
knowledge required to be an ‘expert’ has 
recently been discussed by Ousey et al 
(2011), during an online Wounds UK 
debate. Table 1 illustrates a summary 
of some of the main themes that should 
be taught in pre- and post-registration 
training, to ensure that quality wound 
care education can be maintained.
Healthcare professionals that are active at 
this level of wound care education need to 
be able to critically analyse the evidence, 
in order to recognise its validity and 
reliability and then demonstrate the ability 
to implement it into treatment planning 
and care pathways. It is also essential that 
they understand the importance of inter-
professional and multidisciplinary working.
ThE diAbETiC FOOT
Diabetes is known to increase the 
complications in wounds and in a recent 
study it has been reported that patients 
with diabetes mellitus who have foot 
ulcers are at an increased risk of mortality 
compared with people who have diabetes 
and do not have a foot ulceration, with 
mortality rates being similar to patients 
suffering with common types of cancer 
(Escandon et al, 2011).
Diabetes is currently recognised as one 
of the leading causes of morbidity and 
mortality in the UK (Jeffcoate and Harding, 
2003; Bilous and Donnelly, 2010). It is 
estimated that, worldwide, there are 285 
million people with diabetes, and, of those, 
around three million live in the UK. This 
is anticipated to grow by a further 54% 
worldwide by 2030 (DoH, 2010b; Shaw 
et al, 2010; Holman, 2011). The DoH 
(2010c) describes diabetes as a chronic and 
progressive disease, which has an impact 
on almost all aspects of life. Diabetes is 
a condition that can further affect the 
microvascular and macrovascular system 
(Bilous and Donnelly, 2010).
The context and cost of diabetes in 
healthcare
Diabetes care in the NHS has an 
approximate price tag of £9bn, with up to 
20% (£600m) being used to treat diabetic 
foot problems (Roberts, 2006; NICE, 
2011). The main cause of non-traumatic 
lower limb amputations is diabetic foot 
ulceration (Clayton and Elasy, 2009) and 
it is estimated that £252m is being spent 
annually on amputations (NICE, 2011).  
Recent figures reported by NICE (2011) 
suggest that each year in the UK, around 
5,000 people with diabetes undergo leg, 
foot or toe amputations — equivalent to 
100 occurring each week (NICE, 2011).  
The NICE clinical guidelines for prevention 
and management of type 2 Diabetes 
(NICE, 2004), report figures produced 
by Neil et al (1989), Walters et al (1992), 
Kumar et al (1994) and, more recently, 
Shakher and Stevens (2011), indicating 
that 20–40% of people with diabetes are 
estimated to have neuropathy and about 
5% have a foot ulcer. Recognising those 
people at risk of ulceration is, therefore, 
crucial. Essentially, foot ulceration 
occurs due to neurological, vascular and/
or mechanical force problems. This is 
summarised in Table 2.
wOund bEd PREPARATiOn, 
inFECTiOn And ExudATE 
MAnAgEMEnT 
The use of antimicrobials in wound care 
245  Wounds UK 2012, Vol 8, No 2
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is not a new phenomenon. The current 
trend is looking to reduce the amount 
of antibiotics used as antibiotic-resistant 
bacteria, such as Methicillin-resistant 
Staphylococcus aureus (MRSA), are on 
the increase (Kingsley, 2009). 
Wound care, therefore, needs to 
focus on recognising the early stages 
of infection. All chronic wounds are 
contaminated with bacteria to some 
degree and low levels of bacteria can, in 
certain circumstances, facilitate healing 
(De Haan et al, 1974; Pollack, 1984; 
Kingsley, 2009). When the bacterial 
burden of the wound overtakes the host 
response, this is when clinical signs of 
bacteria are noted. 
bacterial burden
The following terms indicate the bacterial 
numbers in a wound:
Colonisation
Colonised wounds contain multiplying 
bacteria but the host does not have obvious 
clinical symptoms, nor is the healing of 
the wound affected by their presence. All 
wounds have a level of bacterial burden.
Critical Colonisation
Critically colonised wounds require 
a reduction in the bacterial burden if 
the wound is to heal. Chronic wounds 
are often critically colonised and this 
may be identified clinically when the 
wound margins fail to change. Critical 
colonisation may appear as a dull brick 
red colour with an increase in serous 
exudate. Sloughy fibrous tissue may also 
be present, which requires debridement 
and can be an early indicator of possible 
signs of localised infection.
Local and systemic infection
This is recognised as cellulitis, erythema, 
oedema, localised heat, pain and limited 
function, and may include increased 
discharge, wound breakdown, slough and 
odour. Localised infection would be less 
than 2cm and systemic infection greater 
than 2cm. Infection is better treated with 
antibiotics, but can be accompanied by 
topical antimicrobials.
Septicaemia
Septicaemia is characterised by chills, high 
fever, rapid breathing, rapid heart rate 
and the person appearing very ill. This is a 
clinically emergency and requires hospital 
admission for IV antibiotics (Cutting and 
Harding, 1994; Schultz et al, 2003; Edwards 
and Harding, 2004; Kingsley, 2009; Gray et 
al 2010).
As well as wound bed appearance and 
level of infection, the final element in 
wound healing focuses on wound exudate 
levels and viscosity (Vowden and Vowden, 
2004; Gray et al, 2005). The higher the 
viscosity and exudate levels, the higher the 
incidence of infection (Figure 1).
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Table 2
Associated problems with the high risk foot
Vascular neurological
Ischaemia Sensory neuropathy
Gangrene Motor neuropathy
Tissue viability Autonomous neuropathy
Infection Charcot neuro-arthropathy
Mechanical infective
External pressure Osteomyelitis
Altered mechanics leading to internal and 
external pressure issues
Cellulitis
Lymphangitis
Critically colonised wound/ulcer
Other
Tumour
Foreign bodies
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Antiseptics and the role of PhMb in 
wound care 
The use of antimicrobials in the UK 
has been focused historically around 
honey, silver and iodine. The use of 
polyhexamethylene biguinide (PHMB) 
is not currently widespread in the UK, 
however, its use in the US and Europe 
is commonplace, with the European 
consensus being that it is the first-line 
choice for topical antimicrobial therapy 
(Kingsley, 2009; Barrett et al, 2010). 
PHMB is an appropriate first-line 
antimicrobial treatment choice as the 
synthetic compound is a structure similar to 
naturally occurring antimicrobial peptides 
(AMPs) and has a broad spectrum activity 
against bacteria, viruses and fungi (Moore 
and Gray, 2007; Kingsley, 2009). Furthermore, 
PHMB has been in widespread use for 
approximately 60 years with no evidence of 
the development of resistance or cytotoxicity 
(Moore and Gray, 2007; Kingsley, 2009).
CASE STudY
The patient is a 72-year-old man with a 
history of type 2 diabetes mellitus dating back 
approximately 27 years. His self-monitored 
biometric data levels are erratic and his 
HbA1C levels are often recorded at 69–
102mmol/mol (8.5%–11.5%). He has been 
encouraged to commence insulin therapy, 
but refuses due to his fear of needles. 
wound aetiology and wound 
assessment 
While visiting friends, the patient 
developed a small black area on the fourth 
toe of his left foot. On returning home, he 
decided to visit A&E due to the pain in the 
area. He was admitted to hospital that day, 
due to a gangrenous toe with surrounding 
cellulitis. He was prescribed intravenous 
antibiotics and an urgent vascular referral 
was made. Within 24 hours, the vascular 
surgeon had reviewed him and amputated 
his second to fifth toes, while a balloon 
angioplasty was performed to improve the 
circulation to his extremities.
The patient was managed as an in-patient 
for a further week before being discharged. 
He was then initially managed by the district 
nursing service following the vascular 
service’s request for daily dressing changes. 
Within four weeks, the wound deteriorated 
and required specialist podiatrist 
intervention for assessment and appropriate 
sharp debridement (Figure 2). The patient 
was then managed jointly by the district 
nursing service and podiatry services.
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KEY POINTS
 High risk patients must be 
assessed for appropriate wound 
dressing.
 Financial burden on NHS 
remains a problem that may 
be reduced with appropriate 
wound management.
 PHMB is an appropriate first-line 
antimicrobial treatment choice
Volume                           Viscosity
High - 5 Medium - 3 Low - 1
High - 5
Medium - 3
Low -1 
Figure 2: Wound at presentation, post 
debridement. The wound is critically 
colonised. There are no signs of systemic or 
localised infection, therefore, the treatment 
focused on topical antimicrobials
Figure 1: Exudate Continuum (Gray et al, 2005).
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wound at presentation to  
podiatry service
The patient presented to podiatry with an 
ulcer, which was predominantly sloughy at 
the post-operative amputation site with a 
small area of red granulation tissue. There 
was no localised cellulitis, or any cardinal 
sign of surrounding tissue infection, but 
the wound displays signs of a high bacterial 
burden consistent with a classification of 
critical colonisation. 
The wound exudate levels and the viscosity 
of the wound also implied that there was 
a high bacterial burden and if not treated 
appropriately the wound and the localised 
tissue could become infected. Therefore, 
the treatment plan was focused on the use 
of antimicrobial therapy. 
The treatment plan initiated for this patient 
focused primarily on antimicrobial care — 
Suprasorb X +PHMB) (Activa Healthcare) 
was used at the primary dressing — 
with podiatry input for specialist sharp 
debridement and an appropriate secondary 
dressing (Tegaderm Foam Dressing [non-
adhesive]; 3M) to deal with the exudate 
management. 
Due to the potentially prolonged use of the 
antimicrobial dressing, it was felt that silver 
and iodine have a higher potential risk 
factor associated with them, due to known 
sensitivity and systemic absorption noted 
in these antimicrobials. The hydro balance 
nature of Suprasorb X +PHMB also made 
it more favourable than other antimicrobial 
agents available (Kingsley, 2009).
The plan at this stage was to review and 
redress the wound three times per week, 
which was reduced after two weeks to 
biweekly review.
The use of Suprasorb X +PHMB was 
discontinued at eight weeks and replaced 
with a low absorbent dressing. The 
rationale for the change was the reduction 
in exudate volume and viscosity, with 100% 
granulation of the wound bed achieved 
(Figures 3 and 4). The ulcer dressing 
was changed to a low absorbent type at 
this stage due to the wound having 100% 
granulation and low, serous exudate. 
In the ‘at risk’ patient, prophylactic 
antimicrobials may be advantageous, as the 
bacterial host resistance in a person with 
diabetes is decreased and bacteria have 
a relative advantage (Schultz et al, 2003; 
Ousey, 2010). 
The ulcer had almost healed after 12 
weeks and dressing reviews consequently 
reduced to once a week. The ulcer fully 
healed at 14 weeks and remains healed at 
the time of writing. 
COnCluSiOn
Diagnosing the level of risk for a patient and 
optimising healing, requires a multifaceted 
approach. The expertise of multidisciplinary 
foot care teams can maintain optimum care 
pathways that will include critically appraised 
evidence to support decision making. Within 
current wound management pathways, there 
must be recognition of the role of wound 
care products to enhance the healing process. 
PHMB products offer a new dimension 
to antimicrobial wound care, especially 
as current trends show resistance 
to antibiotic therapy. Sensitivity and 
systemic absorption of current topical 
antimicrobials makes product choice 
difficult, therefore, the introduction 
of a low-sensitivity product is always 
welcomed.wuk
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there was a high 
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